Site Search
Displaying results 81 - 90 of 573
Resource | Guidelines,
The National Guidelines for HIV Care and Treatment in PNG are one of the many tools that have been developed to provide healthcare workers with guidance on various aspects of care and treatment. In this, the fifth edition of the Guidelines, there is much wider coverage of such areas as; Adult and Pediatric HIV management including adherence issues; Prevention of Parent-to-Child Transmission (PPTCT); Prophylaxis and Treatment of opportunistic infections (OIs); and management of co-morbidities.
Resource | Publications,
The publication provides information on contraceptive options and choice, the medical eligibility criteria for different methods of contraception for women and adolescent girls living with HIV and using antiretroviral therapy, a summary of the comparative effectiveness of contraceptive methods and contraceptive considerations at different stages of a woman’s life-course.
Resource | Publications,
Although significant progress has been made towards ending AIDS as a public health threat, with 23.3 of the 37.9 million (62%) people living with HIV receiving antiretroviral therapy (ART) by the end of 2018, many gaps in service access and quality remain.
The objective of this brief is to consolidate WHO guidance to support the implementation of high-quality HIV services through approaches to policy, strategy and service delivery, to suggest considerations for selecting measures of high-quality services and to provide case examples of quality management in HIV services in low- and middle- income countries.
Resource | Publications,
These guidelines provide further reassurance of DTG as the preferred antiretroviral (ARV) drug in first- and second-line regimens due to the declining estimate of neural tube defect risk and observed efficacy. This reassurance comes at a time when pretreatment resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTI) is increasing in low- and middle-income countries, creating demand for access to alternative non-NNRTI ARV drugs.
Resource | Publications,
The National STD/AIDS Control Programme (NSACP) of the Ministry of Health is the main government organization which coordinate the national response to sexually transmitted infections including HIV/AIDS in Sri Lanka. It collaborates with many national and international organizations such as the Global Fund to Fight Against AIDS, TB and Malaria (GFATM) and UN organizations while providing leadership and technical support to 33 island wide STD clinics and 21 ART centers. Furthermore, it provides quality STI and HIV laboratory services through a comprehensive laboratory network. National and subnational level monitoring and evaluation and surveillance are other important activities carried out by NSACP.
Resource | Publications,
The publication presents cascade of HIV testing, care and treatment services, 2014–2015 for Bangladesh, Bhutan, India, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand and Timor Leste.
Resource | Publications,
Greatly expanded access to routine viral load testing will be a game-changer in the global response to AIDS. Routine viral load tests improve treatment quality and individual health outcomes for people living with HIV, contribute to prevention, and potentially reduce resource needs for costly second- and third-line HIV medicines.
Resource | Publications,
This report presents background information on Kiribati, its health-care system and the national epidemiology of hepatitis. It then details review findings and recommendations under each priority area of action of the Regional Action Plan for Viral Hepatitis in the Western Pacific 2016–2020: broad-based advocacy and awareness, evidence-based policy guiding comprehensive hepatitis action, data supporting the hepatitis response, stopping transmission, and an accessible and effective treatment cascade.
Resource | Publications,
Due to its characteristics, widespread cultivation and use, and diversity of its applications the Cannabis sativa L. plant directly pertains to at least 62 of the 169 targets found in 15 out of the 17 Sustainable Development Goals (SDGs). Surprisingly, this plant affects the SDGs both positively and negatively.
This report explains how the “hemp-issues” of Cannabis sativa L. (non psychoactivity-related uses) can contribute to meeting Goals 1, 2, 7, 9, 11, 12, 13 and 15, but also why reforming the current repressive, prohibitive, and marginalizing policies relating to “marijuana-issues” (psychoactivity-related uses of Cannabis sativa L.) is indispensable to meet Goals 3, 4, 5, 8, 10, 13, 16 and 17.
Resource | Publications,
WHO is accountable for reporting back to the World Health Assembly on progress in implementing the Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections based on data received from countries. This report assesses the mid-term progress in 2019 in implementing these global health sector strategies from 2016 to 2021.
The timeliness and availability of the data across the three diseases is limited, being for 2016 or 2017 in most cases. Key data, including 2018 impact data on incidence and mortality, were not available for this report, making it difficult to assess and validate overall trends since the launch of the strategies in 2016.